维普期刊资源整合服务平台（V6.5）

70篇 您的检索式：作者名="Occleston"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy显示文摘	Kon CH Occleston NL Charteris D	1998	Invest Ophthalmol Vis Sci1998，39，8：	1
2	Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro显示文摘	Daniels J T Cambrey AD Occleston NL	2007	Invest Ophthalmol Vis Sci2007，48，3：	1
3	A prospective study of matrix metalloproteinases in proliferative vitreorotinopathy显示文摘	Kon CH Occleston NL Charteris D	1998	invest Ophthalmol Vis Sci1998，39，8：	1
4	Detection of melanoma cells in peripheral blood by reverse transcription poly merase chain reaction显示文摘	Foss AJ Guille MJ Occleston NL	1995	BrJ Cancer1995，72，1：	1
5	Aprospective study of matrix metalloproteinases in proliferative vitreoretinopathy显示文摘	Kon CH Occleston NL Charteris DG	1998	Invest Ophthalmol Vis Sci1998，39，：	1
6	Expression of vitreous cytokines in proliferative vitreoretinopathy:a prospective study显示文摘	Kon CH Occleston NL Aylward GW	1999	Invest Ophthalmol Vis Sci1999，40，3：	1
7	Effects of antimetabolite induced cellular growth arrest on fibroblast-fibroblast interactions显示文摘	Daniels JT Occleston NL Crowston JG	1999	Exp Eye Res1999，69，：	1
8	Effects of antimetabolite induced cellular growth arrest on fibroblast-fibroblast interactions显示文摘	Daniels JT Occleston NL Crowston JG	1999	Exp Eye Res1999，69，1：	1
9	Expression of vitreous cytokines in proliferative vireoretinopathy: a prospective study显示文摘	Occleston NL Aylward GW	1999	IOVS1999，40，：	1
10	Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study显示文摘	Kon CH Asaria RH Occleston NL Khan PT Aylward GW	2000	Br J Ophthalmol2000，84，：	1
11	Risk factors for proliferative vitreoretinopathy after primary vltrectomy : a prospective study 显示文摘	Kon CH Asaria RH Occleston NL	2000	Br J Ophthalmol2000，84，：	1
12	Skin and oral fibwblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase active显示文摘	STEPHENS P DAVIES K J OCCLESTON N	2001	Br J Dermatol2001，144，2：	1
13	Prevention and reduc-tion of scarring in the skin by Transforming Growth Factor beta 3(TGFbeta3):from laboratory discovery to clinical pharmaceutical显示文摘	Occleston NL Laverty HG O'Kane S		0，，08：	1
14	A prospective study of mateix metalloproteinases in proliferative vitreoretinopathy显示文摘	Kon CH Occleston NL Charteris D	1998	Invest Ophthalmol Vis Sci1998，39，8：	1
15	Differences in proliferative rate and collagen lattice contraction between endotenon and synovial fibroblasts显示文摘	Khan U Occleston NL Khaw PT	1998	J Hand surg[ Am]1998，23，2：	1
16	A prospective study of matrix metallopreteinases in proliferative vitreoretinopathy显示文摘	Kon CH Occleston NL Charteris D Daniels J Avlward GW Khaw PT	1998	Invest Ophthalmol Vis Sci1998，39，8：	1
17	Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro显示文摘	Daniels JT Cambrey AD Occleston NL		0，，：	1
18	Expression of vitre- ous cytokines in proliferative vitreoretinopathy: a prospective study显示文摘	Kon CH Occleston NL Aylward GW	1999	Invest Ophthalmol Vis Sci1999，40，3：	1
19	Prevention and reduction of scarring in the skin by transforming growth factor beta 3 (TGFbeta3) : from laboratory discover), to clinical pharmaceutical 显示文摘	Occleston NL Laverty HG O' Kane S	2008	J Biomater Sci Polym Ed2008，19，8：	1
20	Expression of vitreous cytokines in proliferative vitreoretinopathy : a prospective study 显示文摘	Kon CH Occleston NL Aylward GW	1999	Invest Ophthalmol Vis Sci1999，40，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示